Tumor perfusion assessed by dynamic contrast-enhanced MRI correlates to the grading of renal cell carcinoma: Initial results

European Journal of Radiology

Volumn 74, Issue 3, 2010, Pages

  Palmowski, Moritz ^a   Schifferdecker, Isabel ^b,c   Zwick, Stefan ^c   Macher Goeppinger, Stephan ^b   Laue, Hendrik ^d   Haferkamp, Axel ^b   Kauczor, Hans Ulrich ^b   Kiessling, Fabian ^a   Hallscheidt, Peter ^b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d FRAUNHOFER MEVIS   (Germany)

Author keywords

DCE MRI; Grading; Perfusion; Renal cell carcinoma

Indexed keywords

DCE MRI; DYNAMIC CONTRAST ENHANCED MRI; DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING; MORPHOLOGICAL ANALYSIS; RENAL CELL; RENAL CELL CARCINOMA; TUMOR AREAS; TUMOR PERFUSION;

BLOOD; ENHANCED RECOVERY; GRADING; MAGNETIC RESONANCE IMAGING; RESONANCE;

TUMORS;

GADOBUTROL;

ADULT; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTERMETHOD COMPARISON; KIDNEY CARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR LOCALIZATION; TUMOR VASCULARIZATION;

CARCINOMA, RENAL CELL; CONTRAST MEDIA; FEMALE; HUMANS; KIDNEY NEOPLASMS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NEOVASCULARIZATION, PATHOLOGIC; ORGANOMETALLIC COMPOUNDS; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC;

EID: 77952880679     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2009.05.042     Document Type: Article

References (23)

1. Jemal A., Tiwari R.C., Murray T., et al. Cancer statistics, 2004. CA Cancer J Clin 54 (2004) 8-29
2. Robson C.J., Churchill B.M., and Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol 101 (1969) 297
3. Uzzo R.G., and Novick A.C. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 166 (2001) 6-18
4. Hallscheidt P., Noeldge G., Schawo S., et al. Advances in the staging of renal cell carcinoma with high-resolution imaging. Rofo 179 (2007) 1236-1242
5. Köhler H.H., Barth P.J., Siebel A., Gerharz E.W., and Bittinger A. Quantitative assessment of vascular surface density in renal cell carcinomas. Br J Urol 77 (1996) 650-654
6. Nelson E.C., Evans C.P., and Lara Jr. P.N. Renal cell carcinoma: current status and emerging therapies. Cancer Treat Rev 33 (2007) 299-313
7. Bjelogrlic S.K., Radulovic S., and Babovic N. Molecular targeting agents in renal cell carcinoma: present strategies and future perspectives. Curr Pharm Des 14 (2008) 1058-1077
8. Kiessling F., Jugold M., Woenne E.C., and Brix G. Non-invasive assessment of vessel morphology and function in tumors by magnetic resonance imaging. Eur Radiol 17 (2007) 2136-2148
9. Rosen M.A., and Schnall M.D. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma. Clin Cancer Res 13 (2007) 770-776
10. Goh V., and Padhani A.R. Imaging tumor angiogenesis: functional assessment using MDCT or MRI?. Abdom Imaging 31 (2006) 194-199
11. Miles K.A. Functional computed tomography in oncology. Eur J Cancer 38 (2003) 2079-2084
12. Tofts P.S., and Kermode A.G. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 17 (1991) 357-367
13. Brix G., Semmler W., Port R., Schad L.R., Layer G., and Lorenz W.J. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 15 (1991) 621-628
14. Michaely H.J., Schoenberg S.O., Oesingmann N., et al. Renal artery stenosis: functional assessment with dynamic MR perfusion measurements-feasibility study. Radiology 238 (2006) 586-596
15. Wang J.H., Min P.Q., Wang P.J., et al. Dynamic CT evaluation of tumor vascularity in renal cell carcinoma. Am J Roentgenol 186 (2006) 1423-1430
16. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin Radiat Oncol 14 (2004) 198-206
17. Radjenovic A., Dall B.J., Ridgway J.P., and Smith M.A. Measurement of pharmacokinetic parameters in histologically graded invasive breast tumours using dynamic contrast-enhanced MRI. Br J Radiol 81 (2008) 120-128
18. de Senneville B.D., Mendichovszky I.A., Roujol S., Gordon I., Moonen C., and Grenier N. Improvement of MRI-functional measurement with automatic movement correction in native and transplanted kidneys. J Magn Reson Imaging 28 (2008) 970-978
19. Delakas D., Karyotis I., Daskalopoulos G., Terhorst B., Lymberopoulos S., and Cranidis A. Nephron-sparing surgery for localized renal cell carcinoma with a normal contralateral kidney: a European three-center experience. Urology 60 (2002) 998-1002
20. Bostwick D.G., and Eble N.J. Diagnosis and classification of renal cell carcinoma. Urol Clin North Am 26 (1999) 627-635
21. Sheir K.Z., El-Azab M., Mosbah A., El-Baz M., and Shaaban A.A. Differentiation of renal cell carcinoma subtypes by multislice computerized tomography. J Urol 174 (2005) 451-455
22. Kim J.K., Kim T.K., Ahn H.J., Kim C.S., Kim K.R., and Cho K.S. Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol 178 (2002) 1499-1506
23. Sun M.R., Ngo L., Genega E.M., et al. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes-correlation with pathologic findings. Radiology 250 (2009) 793-802